¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"diffusion barrier"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • permeability barrier
    Åõ°úÀ庮
  • somatic barrier
    ½ÅüÀ庮
  • sonic barrier
    À½ÆÄÀ庮
  • stimulus barrier
    ÀÚ±ØÀ庮
  • anisotropic diffusion
    ºñµî¹æÈ®»ê
  • antigen diffusion constant
    Ç׿øÈ®»ê»ó¼ö
  • apparent diffusion coefficient
    °Ñº¸±âÈ®»ê°è¼ö
  • agar diffusion method
    ¿ì¹«È®»ê¹ý
  • agar gel diffusion
    ¿ì¹«°ÖÈ®»ê
  • column diffusion method
    ±âµÕÈ®»ê¹æ¹ý
  • diffusion
    È®»ê, ÆÛÁü
  • diffusion chamber
    È®»ê½Ç
  • diffusion circle
    »ê¶õ¿ø
  • diffusion coefficient
    È®»ê°è¼ö
  • diffusion constant
    È®»ê»ó¼ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • potential barrier
    ÀüÀ§À庮
  • somatic barrier
    ½ÅüÀ庮
  • sonic barrier
    À½ÆÄÀ庮
  • stimulus barrier
    ÀÚ±ØÀ庮
  • agar diffusion method
    ¿ì¹«È®»ê¹ý
  • agar gel diffusion
    ¿ì¹«°ÖÈ®»ê
  • anisotropic diffusion
    ºñµî¹æÈ®»ê
  • antigen diffusion constant
    Ç׿øÈ®»ê»ó¼ö
  • apparent diffusion coefficient
    °Ñº¸±âÈ®»ê°è¼ö
  • circulatory diffusion
    ¼øÈ¯È®»ê
  • column diffusion method
    ±âµÕÈ®»ê¹æ¹ý
  • diffusion chamber
    È®»ê½Ç
  • diffusion circle
    »ê¶õ¿ø
  • diffusion coefficient
    È®»ê°è¼ö
  • diffusion constant
    È®»ê»ó¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antigen diffusion constant
    Ç׿øÈ®»ê»ó¼ö(ù÷ê«üªß¤ßÈâ¦).
  • apparent diffusion coefficient (ADC)
    °Ñº¸±â È®»ê °è¼ö
  • free diffusion
    ÀÚÀ¯È®»ê.
  • gas diffusion
    °¡½ºÈ®»ê, °¡½º¹Ì»ê
  • gel diffusion
    ÇÑõȮ»ê
  • gel diffusion precipitin reaction
    ÇÑõȮ»ê ħ°­¹ÝÀÀ
  • gel diffusion test, quantitative
    ÇÑõȮ»ê Á¤·®¹ý
  • heavily diffusion weighted MRI
    Áß È®»ê °­Á¶ ÀÚ±â°ø¸í¿µ»ó
  • identity diffusion
    Á¤Ã¼¼º È®»ê
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • blood-brain barrier
    Ç÷¾×-³ú À庮
  • blood-brain barrier
    Ç÷³úÀ庮(úìÒàî¡Ûú)
  • blood-brain barrier = BBB
    Ç÷³úÀ庮(¡­Òàî¡Ûú)
  • blood-brain/cerebrospinal fluid barrier
    Ç÷-³ú/³úô¼ö¾× À庮.
  • blood-nerve barrier
    Ç÷½Å°æÀ庮(úìãêÌèî¡Ûú)
  • blood-ocular barrier
    Ç÷¾×¾È±¸À庮
  • blood-retinal barrier
    Ç÷¾×¸Á¸·À庮
  • blood-testis barrier
    Ç÷¾×-°íȯÀ庮
  • economic barrier
    °æÁ¦Àû À庮.
  • fluid brain barrier
    ü¾×³úÀ庮(ô÷äûÒàî¡Ûú).
  • gastric mucosal barrier
    À§Á¡¸· À庮
  • hematoencephalic barrier
    Ç÷¾×³ú°ü¹®.
  • institutional barrier
    Á¦µµÀû À庮.
  • interhemal membrane placental barrier
    Ç÷¾×»çÀ̸· Źݰü¹®
  • mucosal barrier
    Á¡¸·À庮(¡­î¡Ûú).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diffusion
    È®»ê(üªß¤)
  • diffusion chamber
    È®»ê½Ç(üªß¤ãø)
  • diffusion coefficient
    È®»ê°è¼ö(üªß¤Ìõâ¦)
  • diffusion constant
    "È®»ê»ó¼ö(üªß¤ßÈâ¦), (ÔÒ) diffusion coefficient"
  • diffusion-limited reaction
    È®»êÁ¦ÇÑ ¹ÝÀÀ(üªß¤ð¤ùÚÚãëë)
  • diffusion potential
    È®»êÀüÀ§(üªß¤ï³êÈ)
  • double diffusion
    ÀÌÁß È®»ê(ì£ñìüªß¤)
  • eddy diffusion
    ¿ÍÈ®»ê(è¾üªß¤)
  • exchange diffusion
    ±³È¯ È®»ê (Îßüµüªß¤)
  • facilitated diffusion
    ÃËÁøÈ®»ê (õµòäüªß¤)
  • film diffusion
    Çʸ§ È®»ê(üªß¤)
  • forced diffusion
    °­Á¦ È®»ê(Ë­ð¤üªß¤)
  • free diffusion
    ÀÚÀ¯ È®»ê(í»ë¦üªß¤)
  • gel diffusion
    Á© È®»ê(üªß¤)
  • lateral diffusion
    Ãø¸éÈ®»ê(ö°Øüüªß¤)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heavily diffusion weighted MRI
    ÁßÈ®»ê°­Á¶ÀÚ±â°ø¸í¿µ»ó
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
  • self diffusion
    ÀÚ°¡È®»ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BCB blood-cerebrospinal fluid barrier; brilliant cresyl blue
BIU barrier isolation unit
BR barrier reared [experimental animals]; baseline recovery; bathroom; bed rest; bedside rounds; biliru...
COBS cesarean-obtained barrier-sustained; chronic organic brain syndrome
GMB gastric mucosal barrier; granulomembranous body
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BTB Blood-Tumour-Barrier
EBA Endothelial barrier antigen
BBBD blood brain barrier disruption
BNB blood nerve barrier
BCB blood-CSF barrier
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • diffusion coefficient
    È®»ê °è¼ö
    Gel ³» È®»ê¹ýÀ» »ç¿ëÇÒ ¶§¿¡ ´Ü¹éÁúÀÇ È®»êÀ²À» Ç¥ÇöÇÏ´Â °è¼ö. ´ëüÀûÀÎ Ç׿øÀÇ ºÐÀÚ·®À» ÃøÁ¤ÇÏ´Â °æ¿ì¿¡ »ç¿ëµÈ´Ù.
  • diffusion factor
    È®»ê ÀÎÀÚ
  • diffusion method
    È®»ê¹ý
  • diffusion rate
    È®»êÀ²
  • double diffusion test
    ÀÌÁß È®»ê ½ÃÇè
  • exchange diffusion
    ±³È¯ È®»ê
  • facilitated diffusion
    ÃËÁø È®»ê, Áß°³ È®»ê
  • heavily diffusion weighted MRI
    ÁßÈ®»ê °­Á¶ Àڱ⠰ø¸í ¿µ»ó
  • law of diffusion
    È®»ê¹ýÄ¢
    ¸ðµç ¹°ÁúÀº °í³óµµ¿¡¼­ Àú³óµµ·Î ¹°ÁúÀÌ À̵¿ÇÑ´Ù.
  • perfusion and diffusion imaging
    °ü·ù È®»ê ¿µ»ó
  • simple diffusion
    ´Ü¼ø È®»ê, ´Ü¼ø È®»ê¹ý
  • thermal diffusion
    ¿­ È®»ê
    È¥ÇÕ À¯Ã¼ÀÇ ³»ºÎ¿¡ ¿Âµµ ±¸¹è°¡ ÀÖÀ» ¶§ ¼ººÐ¿¡ µû¶ó °¢°¢ °í¿Â Ãø°ú Àú¿Â ÃøÀ¸·Î ¸ð¿© ºÐ¸®µÇ´Â Çö»ó.
  • turbulent diffusion
    ¿Í·ù È®»ê
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
gel diffusion precipitin tests Precipitin test's in which the immune precipitate forms in a gel medium (usually agar) into which one or both reactants have diffused; generally classified in two types, in one dimension, and in two dimensions.
Synonym: gel diffusion reactions.
(05 Mar 2000)
gel diffusion precipitin tests in one dimension Precipitin test's in which antigen solution and antibody incorporated in agar are layered in tubes, permitting effective diffusion in the vertical dimension; the antibody-containing agar may be overlaid directly with antigen solution (single (gel) diffusion in one dimension).
(05 Mar 2000)
gel diffusion precipitin tests in two dimensions Precipitin test's made in a layer of agar that permits radial diffusion, in both of the horizontal dimensions, of one or both reactants. Double (gel) diffusion in two dimensions (Ouchterlony test, technique, or method) incorporates antigen and antibody solutions placed in separate wells in a sheet of plain agar, permitting radial diffusion of both reactants; this method is widely used to determine antigenic relationships; the bands of precipitate that form where the reactants meet in optimal concentration are of three patterns, referred to as reaction of identity, reaction of partial identity (cross-reaction), and reaction of nonidentity.
(05 Mar 2000)
gel diffusion reactions Precipitin test's in which the immune precipitate forms in a gel medium (usually agar) into which one or both reactants have diffused; generally classified in two types, in one dimension, and in two dimensions.
Synonym: gel diffusion reactions.
(05 Mar 2000)
passive diffusion See: facilitated transport.
(05 Mar 2000)
classical diffusion <radiobiology> In plasma physics, diffusion due solely to scattering (collisions) of charged particles (with unlike charges) via electrical (Coulomb) interactions. (See also diffusion.)
(09 Oct 1997)
population diffusion coefficient <cell biology> Coefficient that describes the tendency of a population of motile cells to diffuse through the environment. Its use presupposes that the cells move in a random walk.
(18 Nov 1997)
neoclassical diffusion <radiobiology> In a magnetised plasma, _classical_ diffusion refers to transport of particles due to Coulomb collisions, taking the spiral orbits in the magnetic field into account. In a toroidal magnetic field, the actual rate of diffusive transport is much higher due to slow changes in the positions of the centres of the spirals, known as banana orbits.
This faster transport is called _neo-classical_. With very few exceptions the transport in toroidal devices is observed to be 10-100 times larger still, presumably due to small-scale turbulence. The observed transport is called _anomalous_ (although it actually is the normal state).
(09 Oct 1997)
diffusion The process of becoming diffused or widely spread, the spontaneous movement of molecules or other particles in solution, owing to their random thermal motion, to reach a uniform concentration throughout the solvent, a process requiring no addition of energy to the system.
(18 Nov 1997)
diffusion anoxia Diffusion hypoxia severe enough to result in the absence of oxygen in alveolar gas.
(05 Mar 2000)
diffusion chambers, culture Devices used in a technique by which cells or tissues are grown in vitro or, by implantation, in vivo within chambers permeable to diffusion of solutes across the chamber walls. The chambers are used for studies of drug effects, osmotic responses, cytogenic and immunologic phenomena, metabolism, etc., and include tissue cages.
(12 Dec 1998)
diffusion coefficient For the translational diffusion of solutes, diffusion is described by Fick's First Law, that states that the amount of a substance crossing a given area is proportional to the spatial gradient of concentration and the diffusion constant (D), that is related to molecular size and shape. A useful derived relationship is that the mean square distance moved by molecules in time t is 6Dt.
(18 Nov 1997)
diffusion constant For the translational diffusion of solutes, diffusion is described by Fick's First Law, that states that the amount of a substance crossing a given area is proportional to the spatial gradient of concentration and the diffusion constant (D), that is related to molecular size and shape. A useful derived relationship is that the mean square distance moved by molecules in time t is 6Dt.
(18 Nov 1997)
diffusion hypoxia Abrupt transient decrease in alveolar oxygen tension when room air is inhaled at the conclusion of a nitrous oxide anaesthesia, because nitrous oxide diffusing out of the blood dilutes the alveolar oxygen.
(05 Mar 2000)
diffusion limitation The boundary layer hypothesis, that the proliferation of cells in culture is limited by the rate at which some essential component (almost certainly a growth factor) diffuses from the bulk medium into the layer immediately adjacent to the plasma membrane. By spreading out, a cell obtains a supra threshold level of the factor and can divide, if unable to spread (because of crowding or poor adhesion) then the cell will remain in the G0 stage of the cell cycle.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á